GT 1, 4, 5, 6

GT 2 and 3

NEUTRINO

FISSION

POSITRON

FUSION

SOF/PEG/RBV (n = 327)

SOF/RBV (n = 253)

PEG/RBV (n = 243)

SOF/RBV (n = 207)

Placebo (n = 71)

SOF/RBV 12 week (n = 100)

SOF/RBV 16 week (n = 95)

Overall

91%

67%

67%

78%

0%

50%

73%

GT 2

N/A

97%

78%

93%

0%

86%

94%

GT 3

N/A

56%

63%

61%

0%

30%

62%

Noncirrhotic

93%

72%

74%

81%

0%

61%

76%

Cirrhotic

80%

47%

38%

61%

0%

31%

66%